Data suggests new Covid 19 strain brings increased risk of reinfection.
Pfizer and BioNTech are among the vaccine manufacturers insisting they'll be able adapt their products if the Omicron variant continues to spread.
Data suggests the new Covid 19 strain - first identified in South Africa - brings an increased risk of reinfection.
The World Health Organistation's calling it a "variant of concern".
But Jonathan Ball - a professor of molecular virology - says we shouldn't get ourselves into a "frenzy".

Kildare North TD Joe Neville Appointed As Fine Gael Spokesperson On Infrastructure And Delivery
Secondary School Exam Fees Set To Be Reinstated In 2026
Kildare Cancer Survivor Welcomes ‘Right to be Forgotten’ Breakthrough
€2 Million Transport Fund Announced to Support Learners with Disabilities
Fears Surround Potential Job Losses At Claire's Newbridge Store
Previously Paused Social Housing Project In Athy Gets Go-Ahead
Spike in Helpline Calls After Controversial Parade Float
Warmest Day Of The Year So Far As Temperatures Climb